Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bambermycin
2. Flavomycin
3. Flavomycins
4. Flavophospholipol
5. Flavophospholipols
6. Menomycin
7. Moenomycins
1. Flavofosfolipol
2. Gainpro
3. Menomycin
4. Bambermycine [inn-french]
5. Bambermycinum [inn-latin]
6. Bambermicina [inn-spanish]
7. Bambermycin [inn]
8. Einecs 234-246-7
9. Unii-pp922a42v2
10. Pp922a42v2
11. Db11377
12. Ncgc00181293-01
13. Antibiotic Complex, Containing Mainly Moenomycin A And C, Obtained From Cultures Of Streptomyces Bambergiensis, Or The Same Substance Obtained By Any Other Means
14. Antibiotic Complex, Containing Mainly Moenomycin A And C, Obtained From Cultures Of Streptomyces Bambergiensis, Or The Same Substance Obtained By Any Other Means. Bambermycin
Molecular Weight | 1597.6 g/mol |
---|---|
Molecular Formula | C70H109N4O35P |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 35 |
Rotatable Bond Count | 39 |
Exact Mass | 1596.6609982 g/mol |
Monoisotopic Mass | 1596.6609982 g/mol |
Topological Polar Surface Area | 602 Ų |
Heavy Atom Count | 110 |
Formal Charge | 0 |
Complexity | 3390 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 26 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Related Excipient Companies
Excipients by Applications
ABOUT THIS PAGE
67
PharmaCompass offers a list of Flavofosfolipol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flavofosfolipol manufacturer or Flavofosfolipol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flavofosfolipol manufacturer or Flavofosfolipol supplier.
PharmaCompass also assists you with knowing the Flavofosfolipol API Price utilized in the formulation of products. Flavofosfolipol API Price is not always fixed or binding as the Flavofosfolipol Price is obtained through a variety of data sources. The Flavofosfolipol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Flavofosfolipol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flavofosfolipol, including repackagers and relabelers. The FDA regulates Flavofosfolipol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flavofosfolipol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flavofosfolipol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flavofosfolipol supplier is an individual or a company that provides Flavofosfolipol active pharmaceutical ingredient (API) or Flavofosfolipol finished formulations upon request. The Flavofosfolipol suppliers may include Flavofosfolipol API manufacturers, exporters, distributors and traders.
click here to find a list of Flavofosfolipol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Flavofosfolipol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Flavofosfolipol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Flavofosfolipol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Flavofosfolipol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Flavofosfolipol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Flavofosfolipol suppliers with NDC on PharmaCompass.
Flavofosfolipol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flavofosfolipol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flavofosfolipol GMP manufacturer or Flavofosfolipol GMP API supplier for your needs.
A Flavofosfolipol CoA (Certificate of Analysis) is a formal document that attests to Flavofosfolipol's compliance with Flavofosfolipol specifications and serves as a tool for batch-level quality control.
Flavofosfolipol CoA mostly includes findings from lab analyses of a specific batch. For each Flavofosfolipol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flavofosfolipol may be tested according to a variety of international standards, such as European Pharmacopoeia (Flavofosfolipol EP), Flavofosfolipol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flavofosfolipol USP).